High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: First results of a randomized trial

By Verrill Mark  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 41-43

Informa Healthcare

Access to resources Recommend Favorite

A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer

By Modi Shanu  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 107-113

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer

By Wildiers H.  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 463-469

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant

By Tachibana Takayoshi  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1318-1320

Informa Healthcare

Access to resources Recommend Favorite

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

By Fehm Tanja   Müller Volkmar   Aktas Bahriye   Janni Wolfgang   Schneeweiss Andreas   Stickeler Elmar   Lattrich Claus   Löhberg Christian   Solomayer Erich   Rack Brigitte   Riethdorf Sabine   Klein Christoph   Schindlbeck Christian   Brocker Kerstin   Kasimir-Bauer Sabine   Wallwiener Diethelm   Pantel Klaus  

Breast Cancer Research and Treatment, Vol. 124, Iss. 2, 2010-11 ,pp. : 403-412

Springer Publishing Company

Access to resources Recommend Favorite